Effects of sitagliptin as add on blood glucose level in patients with type 2 diabetes in national hospital of endocrinology

To evaluate effects of dipeptidyl peptidase (DPP)-4 inbibitors sitagliptin as addon therapy on blood glucose in patients with type 2 diabetes inadequately controlled with oral antidiabetic drug (OAD) monotherapy or combination.